article_snippet.sent: A team led by Imperial College London has already applied to patent the therapy, which A team led by Imperial College London say could be ready for human trials within three years.
article_snippet.sent: The development, which also involved researchers from Queen Mary University of London, ETH Zurich in Switzerland and Harvard Medical School in the US, has already been six years in the making.
article_snippet.sent: A team led by Imperial College London (pictured) has already applied to patent the therapy, which A team led by Imperial College London (pictured) say could be ready for human trials within three years .
article_snippet.sent: If all goes well, we hope to be ready to carry out human trials in about three years.
article_snippet.sent: Imperial College has already filed two patents for the technology, and a spin-off company called ImmunarT has been formed with the aim of commercialising the therapy.
article_snippet.sent: Dr Mike Turner of the Wellcome Trust, which helped fund the research, said:
highlights_snippet.sent: Imperial College London say human trials of therapy could begin in 3 years .
  